Pyrimidine substituted macrocyclic HCV inhibitors

Details for Australian Patent Application No. 2008212758 (hide)

Owner Tibotec Pharmaceuticals Ltd. Medivir AB

Inventors Nilsson, Karl Magnus; Classon, Bjorn Olof; Raboisson, Pierre Jean-Marie Bernard; Belfrage, Anna Karin Gertrud Linnea; Wahling, Horst Jurgen; Rosenquist, Asa Annica Kristina; Lindquist, Karin Charlotta; Samuelsson, Bengt Bertil

Agent Shelston IP

Pub. Number AU-A-2008212758

PCT Pub. Number WO2008/095999

Priority 07102005.1 08.02.07 EP

Filing date 8 February 2008

Wipo publication date 14 August 2008

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

9 July 2009 PCT application entered the National Phase

  PCT publication WO2008/095999 Priority application(s): WO2008/095999

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008212760-HCV inhibiting macrocyclic phenylcarbamates

2008212754-Peptidic and non peptidic ligands for immunodetection of the receptor for urotensin II